BFB759 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02-28 in 4mo
ESTIMATED |
READOUT
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Phase 2 · Atopic Dermatitis (AD) |
Bluefin Biomedicine, Inc. | BFB759 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-28
Sponsor-projected date — can change
|